These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
737 related articles for article (PubMed ID: 22419276)
1. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Rojas-Reyes MX; Morley CJ; Soll R Cochrane Database Syst Rev; 2012 Mar; (3):CD000510. PubMed ID: 22419276 [TBL] [Abstract][Full Text] [Related]
2. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS. Stevens TP; Blennow M; Soll RF Cochrane Database Syst Rev; 2002; (2):CD003063. PubMed ID: 12076469 [TBL] [Abstract][Full Text] [Related]
3. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Stevens TP; Blennow M; Soll RF Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470 [TBL] [Abstract][Full Text] [Related]
4. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Soll RF; Morley CJ Cochrane Database Syst Rev; 2001; (2):CD000510. PubMed ID: 11405966 [TBL] [Abstract][Full Text] [Related]
5. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Stevens TP; Harrington EW; Blennow M; Soll RF Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD003063. PubMed ID: 17943779 [TBL] [Abstract][Full Text] [Related]
6. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Bahadue FL; Soll R Cochrane Database Syst Rev; 2012 Nov; 11(11):CD001456. PubMed ID: 23152207 [TBL] [Abstract][Full Text] [Related]
7. Continuous positive airway pressure (CPAP) for respiratory distress in preterm infants. Ho JJ; Subramaniam P; Davis PG Cochrane Database Syst Rev; 2020 Oct; 10(10):CD002271. PubMed ID: 33058208 [TBL] [Abstract][Full Text] [Related]
8. Continuous distending pressure for respiratory distress in preterm infants. Ho JJ; Subramaniam P; Davis PG Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD002271. PubMed ID: 26141572 [TBL] [Abstract][Full Text] [Related]
9. Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress syndrome. Sibrecht G; Kearl CR; Borys F; Morariu M; Bruschettini M; Soll R Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013158. PubMed ID: 37882216 [TBL] [Abstract][Full Text] [Related]
10. Comparison of animal-derived surfactants for the prevention and treatment of respiratory distress syndrome in preterm infants. Singh N; Halliday HL; Stevens TP; Suresh G; Soll R; Rojas-Reyes MX Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD010249. PubMed ID: 26690260 [TBL] [Abstract][Full Text] [Related]
11. Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome. Pfister RH; Soll RF; Wiswell T Cochrane Database Syst Rev; 2007 Jul; (3):CD006069. PubMed ID: 17636826 [TBL] [Abstract][Full Text] [Related]
12. Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome. Ardell S; Pfister RH; Soll R Cochrane Database Syst Rev; 2015 May; (5):CD000144. PubMed ID: 26009996 [TBL] [Abstract][Full Text] [Related]
13. Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome. Pfister RH; Soll RF; Wiswell T Cochrane Database Syst Rev; 2007 Oct; (4):CD006069. PubMed ID: 17943881 [TBL] [Abstract][Full Text] [Related]
14. Protein-containing synthetic surfactant versus protein-free synthetic surfactant for the prevention and treatment of respiratory distress syndrome. Pfister RH; Soll R; Wiswell TE Cochrane Database Syst Rev; 2009 Oct; (4):CD006180. PubMed ID: 19821357 [TBL] [Abstract][Full Text] [Related]
15. Animal derived surfactant extract for treatment of respiratory distress syndrome. Seger N; Soll R Cochrane Database Syst Rev; 2009 Apr; (2):CD007836. PubMed ID: 19370695 [TBL] [Abstract][Full Text] [Related]
16. Early versus delayed continuous positive airway pressure (CPAP) for respiratory distress in preterm infants. Ho JJ; Subramaniam P; Sivakaanthan A; Davis PG Cochrane Database Syst Rev; 2020 Oct; 10(10):CD002975. PubMed ID: 33058139 [TBL] [Abstract][Full Text] [Related]
17. Prophylactic protein free synthetic surfactant for preventing morbidity and mortality in preterm infants. Soll R; Ozek E Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD001079. PubMed ID: 20091513 [TBL] [Abstract][Full Text] [Related]
18. Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome. Abdel-Latif ME; Osborn DA Cochrane Database Syst Rev; 2011 Jul; (7):CD008309. PubMed ID: 21735428 [TBL] [Abstract][Full Text] [Related]
19. Prophylactic versus selective use of surfactant for preventing morbidity and mortality in preterm infants. Soll RF; Morley CJ Cochrane Database Syst Rev; 2000; (2):CD000510. PubMed ID: 10796379 [TBL] [Abstract][Full Text] [Related]
20. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Yost CC; Soll RF Cochrane Database Syst Rev; 2000; (2):CD001456. PubMed ID: 10796266 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]